19-48966341-G-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PP5_Moderate
The NM_000146.4(FTL):c.310G>T(p.Glu104*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,461,864 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.000014 ( 0 hom. )
Consequence
FTL
NM_000146.4 stop_gained
NM_000146.4 stop_gained
Scores
5
1
1
Clinical Significance
Conservation
PhyloP100: 9.68
Genes affected
FTL (HGNC:3999): (ferritin light chain) This gene encodes the light subunit of the ferritin protein. Ferritin is the major intracellular iron storage protein in prokaryotes and eukaryotes. It is composed of 24 subunits of the heavy and light ferritin chains. Variation in ferritin subunit composition may affect the rates of iron uptake and release in different tissues. A major function of ferritin is the storage of iron in a soluble and nontoxic state. Defects in this light chain ferritin gene are associated with several neurodegenerative diseases and hyperferritinemia-cataract syndrome. This gene has multiple pseudogenes. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 19-48966341-G-T is Pathogenic according to our data. Variant chr19-48966341-G-T is described in ClinVar as [Pathogenic]. Clinvar id is 96690.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FTL | NM_000146.4 | c.310G>T | p.Glu104* | stop_gained | 3/4 | ENST00000331825.11 | NP_000137.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FTL | ENST00000331825.11 | c.310G>T | p.Glu104* | stop_gained | 3/4 | 1 | NM_000146.4 | ENSP00000366525.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251406Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135902
GnomAD3 exomes
AF:
AC:
4
AN:
251406
Hom.:
AF XY:
AC XY:
4
AN XY:
135902
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461864Hom.: 0 Cov.: 32 AF XY: 0.0000206 AC XY: 15AN XY: 727230
GnomAD4 exome
AF:
AC:
20
AN:
1461864
Hom.:
Cov.:
32
AF XY:
AC XY:
15
AN XY:
727230
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
3
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 03, 2022 | The c.310G>T (p.E104*) alteration, located in exon 3 (coding exon 3) of the FTL gene, consists of a G to T substitution at nucleotide position 310. This changes the amino acid from a glutamic acid (E) to a stop codon at amino acid position 104. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on the available evidence, the FTL c.310G>T (p.E104*) alteration is classified as pathogenic for autosomal dominant and autosomal recessive L-ferritin deficiency; however, its clinical significance for autosomal dominant FTL-related neurodegeneration with brain iron accumulation and autosomal dominant hyperferritinemia-cataract syndrome is unclear. Based on data from gnomAD, the T allele has an overall frequency of 0.002% (4/251406) total alleles studied. The highest observed frequency was 0.003% (1/30616) of South Asian alleles. This mutation has been reported in the homozygous state in an individual with L-ferritin deficiency (Cozzi, 2013). Based on the available evidence, this alteration is classified as pathogenic. - |
L-ferritin deficiency, autosomal recessive Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 26, 2013 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at